Dow Chemical Company’s Edwards Lifesciences EW Stock Holding History

Dow Chemical Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-186,000	Closed	-$3.17M	–	88
2014 Q3	$3.17M	Sell	186,000 -42,000	-18%	-$663K	0.28%	39
2014 Q2	$3.26M	Hold	228,000	–	–	0.27%	44
2014 Q1	$2.82M	Buy	228,000 +168,000	+280%	+$1.94M	0.23%	47
2013 Q4	$658K	Sell	60,000 -150,000	-71%	-$1.69M	0.05%	67
2013 Q3	$2.44M	Buy	+210,000	New	+$2.46M	0.2%	38

Other funds holding EW

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dow Chemical Company's EW Position: Q4 2014 in Review

Dow Chemical Company sold out of Edwards Lifesciences (EW) in Q4 2014, closing a stake of 186,000 shares — an estimated $3.17M sold.

Dow Chemical Company first reported a position in EW in Q3 2013 and held it in 5 quarters. The position peaked at $3.26M in Q2 2014. 557 funds tracked by Wall St. Rank hold EW as of Q4 2014.

Dow Chemical Company reported no remaining Edwards Lifesciences position as of Q4 2014 after selling out during the quarter.
Dow Chemical Company sold 186,000 Edwards Lifesciences shares in Q4 2014, an estimated $3.17M.
Dow Chemical Company first reported a position in Edwards Lifesciences in Q3 2013 and held it in 5 quarters.
Dow Chemical Company's Edwards Lifesciences position peaked at $3.26M in Q2 2014.
557 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on Dow Chemical Company's 13F filing for Q4 2014, filed 13 Feb 2015.